{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:06:17Z","timestamp":1793070377189,"version":"4.5.0"},"reference-count":107,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2024,6,11]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>The global impacts of pulmonary hypertension (PH) were formally recognised in 1973 at the 1st World Health Organization meeting dedicated to primary pulmonary hypertension, held in Geneva. Investigations into disease pathogenesis and classification led to the development of numerous therapies over the ensuing decades. While the impacts of the disease have been lessened due to treatments, the symptoms and adverse effects of PH and its therapies on patients\u2019 wellbeing and mental health remain significant. As such, there is a critical need to enhance understanding of the challenges patients face on a global scale with respect to care access, multidimensional patient support and advocacy. In addition, thoughtful analysis of the potential benefits and utilisation of mechanisms for the incorporation of patient-reported outcomes into diagnosis and treatment plans is needed. A summary of these areas is included here. We present a report of global surveys of patient and provider experiences and challenges regarding care access and discuss possible solutions. Also addressed is the current state of PH patient associations around the world. Potential ways to enhance patient associations and enable them to provide the utmost support are discussed. A summary of relevant patient-reported outcome measures to assess health-related quality of life in PH is presented, with suggestions regarding incorporation of these tools in patient care and research. Finally, information on how current global threats such as pandemics, climate change and armed conflict may impact PH patients is offered, along with insights as to how they may be mitigated with advanced contingency planning.<\/jats:p>","DOI":"10.1183\/13993003.01129-2024","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T09:26:34Z","timestamp":1724923594000},"page":"2401129","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Exploring the patient perspective in pulmonary hypertension"],"prefix":"10.1183","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2057-3914","authenticated-orcid":false,"given":"H. James","family":"Ford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pisana","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Meszaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9512-3825","authenticated-orcid":false,"given":"Victor M.","family":"Moles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hall","family":"Skaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3475-8832","authenticated-orcid":false,"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-9252","authenticated-orcid":false,"given":"J. Simon R.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"2024112623045922000_64.4.2401129.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01919-2018"},{"key":"2024112623045922000_64.4.2401129.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac237"},{"key":"2024112623045922000_64.4.2401129.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022"},{"key":"2024112623045922000_64.4.2401129.4","unstructured":"Heine J . The Global South is on the rise \u2013 but what exactly is the Global South? The Conversation, 2023. https:\/\/theconversation.com\/the-global-south-is-on-the-rise-but-what-exactly-is-the-global-south-207959. Date last updated: 3 July 2023."},{"key":"2024112623045922000_64.4.2401129.5","doi-asserted-by":"crossref","first-page":"e26139","DOI":"10.1016\/j.heliyon.2024.e26139","article-title":"International trends in pulmonary hypertension mortality between 2001 and 2019: retrospective analysis of the WHO mortality database","volume":"10","author":"Lin","year":"2024","journal-title":"Heliyon"},{"key":"2024112623045922000_64.4.2401129.6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.21037\/cdt.2019.07.06","article-title":"Pulmonary hypertension in low- and middle-income countries with focus on sub-Saharan Africa","volume":"10","author":"Dzudie","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"2024112623045922000_64.4.2401129.7","first-page":"e202002","article-title":"Pulmonary vascular disease in Africa: lessons from registries","volume":"2020","author":"Mocumbi","year":"2020","journal-title":"Glob Cardiol Sci Pract"},{"key":"2024112623045922000_64.4.2401129.8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijcard.2018.02.036","article-title":"Pulmonary hypertension registry of Kerala, India (PRO-KERALA) \u2013 clinical characteristics and practice patterns","volume":"265","author":"Harikrishnan","year":"2018","journal-title":"Int J Cardiol"},{"key":"2024112623045922000_64.4.2401129.9","unstructured":"Pepke-Zaba JG , Newman, JM , et al. Pulmonary hypertension global patient survey: an overview and preliminary results. Pulmonary Vascular Research Institute Annual Congress, 2024. 2 February 2024. London, UK."},{"key":"2024112623045922000_64.4.2401129.10","doi-asserted-by":"crossref","first-page":"e12247","DOI":"10.1002\/pul2.12247","article-title":"Patient perspectives on pulmonary hypertension in the United States: burdens, expectations, and goals","volume":"13","author":"Braley","year":"2023","journal-title":"Pulm Circ"},{"key":"2024112623045922000_64.4.2401129.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.047"},{"key":"2024112623045922000_64.4.2401129.12","unstructured":"European Lung Foundation . Pulmonary Hypertension \u2013 Understanding the Professional Guidelines. https:\/\/europeanlung.org\/en\/information-hub\/guidelines\/diagnosing-and-treating-pulmonary-hypertension-understanding-the-professional-guidelines\/. Date last accessed 2 March 2024. Date last updated: 6 March 2024."},{"key":"2024112623045922000_64.4.2401129.13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ejhf.2830","article-title":"European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology","volume":"25","author":"Aktaa","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2024112623045922000_64.4.2401129.14","unstructured":"NHS England . National Audit of Pulmonary Hypertension 14th Annual Report. 2023. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/national-pulmonary-hypertension-audit\/14th-annual-report. Date last accessed: 9 February 2024."},{"key":"2024112623045922000_64.4.2401129.15","doi-asserted-by":"crossref","first-page":"765461","DOI":"10.3389\/fmed.2022.765461","article-title":"Risk factors and intervention for depression and anxiety in pulmonary hypertension: a systematic review and meta-analysis","volume":"9","author":"Mai","year":"2022","journal-title":"Front Med"},{"key":"2024112623045922000_64.4.2401129.16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01325-2024"},{"key":"2024112623045922000_64.4.2401129.17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.chest.2022.08.2231","article-title":"Assessing daily life physical activity by actigraphy in pulmonary arterial hypertension: insights from the randomized controlled study with selexipag (TRACE)","volume":"163","author":"Howard","year":"2023","journal-title":"Chest"},{"key":"2024112623045922000_64.4.2401129.18","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.chest.2019.06.010","article-title":"Monitoring pulmonary arterial hypertension using an implantable hemodynamic sensor","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"key":"2024112623045922000_64.4.2401129.19","doi-asserted-by":"crossref","first-page":"e12173","DOI":"10.1002\/pul2.12173","article-title":"Nutritional status in pulmonary arterial hypertension","volume":"12","author":"Kwant","year":"2022","journal-title":"Pulm Circ"},{"key":"2024112623045922000_64.4.2401129.20","doi-asserted-by":"publisher","DOI":"10.1086\/677365"},{"key":"2024112623045922000_64.4.2401129.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01180-2024"},{"key":"2024112623045922000_64.4.2401129.22","unstructured":"World Health Organization . eHealth. www.emro.who.int\/health-topics\/ehealth\/. Date last accessed: 20 February 2024."},{"key":"2024112623045922000_64.4.2401129.23","unstructured":"PHA Europe . PAH Patient Charter. 2021. www.janssenwithme.com\/en\/pulmonary-arterial-hypertension\/ph-human\/patient-charter. Date last accessed: 21 February 2024."},{"key":"2024112623045922000_64.4.2401129.24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41562-021-01056-1","article-title":"Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA","volume":"5","author":"Loomba","year":"2021","journal-title":"Nat Hum Behav"},{"key":"2024112623045922000_64.4.2401129.25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41586-023-06883-y","article-title":"Online searches to evaluate misinformation can increase its perceived veracity","volume":"625","author":"Aslett","year":"2024","journal-title":"Nature"},{"key":"2024112623045922000_64.4.2401129.26","unstructured":"World Health Organization . Environmental Health in Emergencies and Disasters: a Practical Guide. 2002. www.who.int\/publications\/i\/item\/9241545410."},{"key":"2024112623045922000_64.4.2401129.27","doi-asserted-by":"publisher","DOI":"10.1186\/s13031-017-0119-8"},{"key":"2024112623045922000_64.4.2401129.28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13031-015-0045-6","article-title":"Assessments of health services availability in humanitarian emergencies: a review of assessments in Haiti and Sudan using a health systems approach","volume":"9","author":"Nickerson","year":"2015","journal-title":"Confl Health"},{"key":"2024112623045922000_64.4.2401129.29","unstructured":"World Health Organization . Climate Change and Health: Report by the Secretariat. A61\/14. Geneva, World Health Organization, 2008. https:\/\/cdn.who.int\/media\/docs\/default-source\/climate-change\/report-by-the-secretariat-on-climate-change-and-health.pdf."},{"key":"2024112623045922000_64.4.2401129.30","unstructured":"World Health Organization . The 1.5 Health Report. Synthesis on Health and Climate Science in the IPCC SR1.5. Geneva, World Health Organization, 2018. https:\/\/apo.who.int\/publications\/i\/item\/the-1.5-health-report."},{"key":"2024112623045922000_64.4.2401129.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32290-X"},{"key":"2024112623045922000_64.4.2401129.32","doi-asserted-by":"crossref","first-page":"e2331745","DOI":"10.1001\/jamanetworkopen.2023.31745","article-title":"War and health care services utilization for chronic diseases in rural and semiurban areas of Tigray, Ethiopia","volume":"6","author":"Gebrehiwet","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2024112623045922000_64.4.2401129.33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1513\/AnnalsATS.201510-661PS","article-title":"War is the enemy of health. Pulmonary, critical care, and sleep medicine in war-torn Syria","volume":"13","author":"Sahloul","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2024112623045922000_64.4.2401129.34","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/heapol\/czab042","article-title":"eHealth for service delivery in conflict: a narrative review of the application of eHealth technologies in contemporary conflict settings","volume":"36","author":"Bowsher","year":"2021","journal-title":"Health Policy Plan"},{"key":"2024112623045922000_64.4.2401129.35","doi-asserted-by":"publisher","DOI":"10.1186\/s13031-021-00345-w"},{"key":"2024112623045922000_64.4.2401129.36","unstructured":"PHA Europe . Addressing the Unmet Needs of Persons Living with Pulmonary Hypertension: a Call to Action. 2022. www.phaeurope.org\/get-involved\/advocacy-policy-work\/call-to-action-on-unmet-needs-of-patients-with-pulmonary-hypertension-2022\/."},{"key":"2024112623045922000_64.4.2401129.37","unstructured":"World Health Organization . WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care. Geneva, World Health Organization, 2020. https:\/\/iris.who.int\/bitstream\/handle\/10665\/334186\/9789240009226-eng.pdf?sequence=1. Date last accessed: 26 March 2024."},{"key":"2024112623045922000_64.4.2401129.38","unstructured":"European Kidney Health Alliance . 2019 European Commission Thematic Network on Organ Donation and Transplantation. https:\/\/ekha.eu\/policy\/2019-eu-thematic-network-on-organ-donation-and-transplantation. Date last accessed: 16 February 2024."},{"key":"2024112623045922000_64.4.2401129.39","unstructured":"European Respiratory Society . Proposed Revision to the EU General Pharmaceutical Legislation is a Step in the Right Direction. 2023. www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction. Date last accessed: 16 February 2024."},{"key":"2024112623045922000_64.4.2401129.40","unstructured":"PHA Europe . The European Health Data Space. 2023. www.phaeurope.org\/news\/the-european-health-data-space. Date last accessed: 16 February 2024."},{"key":"2024112623045922000_64.4.2401129.41","unstructured":"European Medicines Agency . Criteria to be Fulfilled by Patient, Consumer and Healthcare Professional Organisations Involved in European Medicines Agency (EMA) Activities. 2018. www.ema.europa.eu\/system\/files\/documents\/regulatory-procedural-guideline\/wc500018099_en.pdf."},{"key":"2024112623045922000_64.4.2401129.42","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202108_26455"},{"key":"2024112623045922000_64.4.2401129.43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12890-019-0827-5","article-title":"The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients","volume":"19","author":"Armstrong","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2024112623045922000_64.4.2401129.44","unstructured":"Devlin NJ , Appleby J . Getting the Most Out of PROMs. Putting Health Outcomes at the Heart of NHS Decision-Making. 2010. https:\/\/assets.kingsfund.org.uk\/f\/256914\/x\/574e14d9f7\/getting_most_out_proms_2010.pdf. Date last accessed: 18 February 2024."},{"key":"2024112623045922000_64.4.2401129.45","unstructured":"Food and Drug Administration . Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009. www.fda.gov\/media\/77832\/download. Date last accessed: 6 May 2024."},{"key":"2024112623045922000_64.4.2401129.46","unstructured":"European Medicines Agency . Patient Experience Data in EU Medicines Development and Regulatory Decision-Making. 2022. www.ema.europa.eu\/en\/documents\/other\/executive-summary-patient-experience-data-eu-medicines-development-and-regulatory-decision-making-workshop_en.pdf."},{"key":"2024112623045922000_64.4.2401129.47","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-013-0390-0"},{"key":"2024112623045922000_64.4.2401129.48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jval.2016.11.005","article-title":"Clinician-reported outcome assessments of treatment benefit: report of the ISPOR clinical outcome assessment emerging good practices task force","volume":"20","author":"Powers","year":"2017","journal-title":"Value Health"},{"key":"2024112623045922000_64.4.2401129.49","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.chest.2022.08.2206","article-title":"Considerations when selecting patient-reported outcome measures for assessment of health-related quality of life in patients with pulmonary hypertension: a narrative review","volume":"162","author":"Yarlas","year":"2022","journal-title":"Chest"},{"key":"2024112623045922000_64.4.2401129.50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11136-023-03505-y","article-title":"Patient adherence to patient-reported outcome measure (PROM) completion in clinical care: current understanding and future recommendations","volume":"33","author":"Unni","year":"2024","journal-title":"Qual Life Res"},{"key":"2024112623045922000_64.4.2401129.51","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-007-9295-0"},{"key":"2024112623045922000_64.4.2401129.52","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-211"},{"key":"2024112623045922000_64.4.2401129.53","first-page":"CD011589","article-title":"Routine provision of feedback from patient-reported outcome measurements to healthcare providers and patients in clinical practice","volume":"10","author":"Gibbons","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2024112623045922000_64.4.2401129.54","doi-asserted-by":"crossref","first-page":"e010280","DOI":"10.1161\/CIRCHEARTFAILURE.122.010280","article-title":"Impact of patient-reported outcome measurement in heart failure clinic on clinician health status assessment and patient experience: a substudy of the PRO-HF trial","volume":"16","author":"Sandhu","year":"2023","journal-title":"Circ Heart Fail"},{"key":"2024112623045922000_64.4.2401129.55","doi-asserted-by":"crossref","first-page":"e0232752","DOI":"10.1371\/journal.pone.0232752","article-title":"Patient-reported outcomes predict return to work and health-related quality of life six months after cardiac rehabilitation: results from a German multi-centre registry (OutCaRe)","volume":"15","author":"Salzwedel","year":"2020","journal-title":"PLoS One"},{"key":"2024112623045922000_64.4.2401129.56","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7818"},{"key":"2024112623045922000_64.4.2401129.57","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-008-9417-3"},{"key":"2024112623045922000_64.4.2401129.58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006560.pub3"},{"key":"2024112623045922000_64.4.2401129.59","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jchf.2023.09.008","article-title":"Clinical utility of patient-reported outcome instruments in the management of pulmonary hypertension: a systematic review","volume":"12","author":"Rose","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2024112623045922000_64.4.2401129.60","doi-asserted-by":"crossref","first-page":"106525","DOI":"10.1016\/j.rmed.2021.106525","article-title":"The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"186","author":"Hendriks","year":"2021","journal-title":"Respir Med"},{"key":"2024112623045922000_64.4.2401129.61","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-005-3513-4"},{"key":"2024112623045922000_64.4.2401129.62","doi-asserted-by":"crossref","first-page":"2045894021995055","DOI":"10.1177\/2045894021995055","article-title":"A minimal clinically important difference measured by the Cambridge Pulmonary Hypertension Outcome Review for patients with idiopathic pulmonary arterial hypertension","volume":"11","author":"Bunclark","year":"2021","journal-title":"Pulm Circ"},{"key":"2024112623045922000_64.4.2401129.63","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-13-45"},{"key":"2024112623045922000_64.4.2401129.64","unstructured":"MAPI Research Trust . Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR). https:\/\/eprovide.mapi-trust.org\/instruments\/cambridge-pulmonary-hypertension-outcome-review. Date last accessed: 1 April 2024."},{"key":"2024112623045922000_64.4.2401129.65","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00127113"},{"key":"2024112623045922000_64.4.2401129.66","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00414-2020"},{"key":"2024112623045922000_64.4.2401129.67","unstructured":"MAPI Research Trust . emPHasis-10. https:\/\/eprovide.mapi-trust.org\/instruments\/emphasis-10#coas_member_access_content. Date last accessed: 1 April 2024."},{"key":"2024112623045922000_64.4.2401129.68","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-161"},{"key":"2024112623045922000_64.4.2401129.69","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12931-016-0388-6","article-title":"Development of the Pulmonary Arterial Hypertension \u2013 Symptoms and Impact (PAH-SYMPACT\u00ae) questionnaire: a new patient-reported outcome instrument for PAH","volume":"17","author":"McCollister","year":"2016","journal-title":"Respir Res"},{"key":"2024112623045922000_64.4.2401129.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.04.027"},{"key":"2024112623045922000_64.4.2401129.71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s41687-021-00327-9","article-title":"Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension \u2013 Symptoms and Impact (PAH-SYMPACTTM) questionnaire in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a qualitative interview study","volume":"5","author":"Currie","year":"2021","journal-title":"J Patient Rep Outcomes"},{"key":"2024112623045922000_64.4.2401129.72","unstructured":"MAPI Research Trust . Pulmonary Arterial Hypertension \u2013 Symptoms and Impact (PAH-SYMPACT\u00ae) Questionnaire (PAH-SYMPACT\u00ae). https:\/\/eprovide.mapi-trust.org\/instruments\/pulmonary-arterial-hypertension-symptoms-and-impact-pah-sympact-r-questionnaire#basic_description. Date last accessed: 2 April 2024."},{"key":"2024112623045922000_64.4.2401129.73","doi-asserted-by":"publisher","DOI":"10.1891\/1061-3749.24.1.40"},{"key":"2024112623045922000_64.4.2401129.74","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2024112623045922000_64.4.2401129.75","unstructured":"MAPI Research Trust . EuroQoL 5-Dimension 5-Level (EQ-5D-5L). https:\/\/eprovide.mapi-trust.org\/instruments\/euroqol-5-dimension-5-level. Date last accessed: 2 April 2024."},{"key":"2024112623045922000_64.4.2401129.76","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201412-572OC"},{"key":"2024112623045922000_64.4.2401129.77","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"2024112623045922000_64.4.2401129.78","unstructured":"MAPI Research Trust . SF-36 Health Survey (SF-36\u00ae\/SF-36v2\u00ae). https:\/\/eprovide.mapi-trust.org\/instruments\/sf-36-health-survey. Date last accessed: 2 April 2024."},{"key":"2024112623045922000_64.4.2401129.79","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13254"},{"key":"2024112623045922000_64.4.2401129.80","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h54"},{"key":"2024112623045922000_64.4.2401129.81","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s41687-018-0061-6","article-title":"How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis","volume":"2","author":"Greenhalgh","year":"2018","journal-title":"J Patient Rep Outcomes"},{"key":"2024112623045922000_64.4.2401129.82","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2023.PA1192"},{"key":"2024112623045922000_64.4.2401129.83","doi-asserted-by":"crossref","first-page":"e12143","DOI":"10.1002\/pul2.12143","article-title":"The feasibility and value of assessing patient-reported outcomes in pulmonary arterial hypertension","volume":"12","author":"DuBrock","year":"2022","journal-title":"Pulm Circ"},{"key":"2024112623045922000_64.4.2401129.84","unstructured":"NHS England . National Pulmonary Hypertension Audit, Past Publications. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/national-pulmonary-hypertension-audit#past-publications. Date last accessed: 23 March 2024."},{"key":"2024112623045922000_64.4.2401129.85","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1093\/eurheartj\/ehad514","article-title":"Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and management","volume":"44","author":"Moons","year":"2023","journal-title":"Eur Heart J"},{"key":"2024112623045922000_64.4.2401129.86","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-021-03003-z"},{"key":"2024112623045922000_64.4.2401129.87","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)01601-4"},{"key":"2024112623045922000_64.4.2401129.88","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-020-02625-z"},{"key":"2024112623045922000_64.4.2401129.89","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9848-0"},{"key":"2024112623045922000_64.4.2401129.90","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/eurheartj\/ehab835","article-title":"Patient partnership in cardiovascular clinical trials","volume":"43","author":"Zannad","year":"2022","journal-title":"Eur Heart J"},{"key":"2024112623045922000_64.4.2401129.91","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/hex.13207","article-title":"Understanding multi-stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: a mixed-methods study","volume":"24","author":"Faulkner","year":"2021","journal-title":"Health Expect"},{"key":"2024112623045922000_64.4.2401129.92","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4738"},{"key":"2024112623045922000_64.4.2401129.93","doi-asserted-by":"publisher","DOI":"10.1086\/686489"},{"key":"2024112623045922000_64.4.2401129.94","doi-asserted-by":"crossref","first-page":"e12111","DOI":"10.1002\/pul2.12111","article-title":"Social determinants of health in pulmonary arterial hypertension patients in the United States: clinician perspective and health policy implications","volume":"12","author":"Nadipelli","year":"2022","journal-title":"Pulm Circ"},{"key":"2024112623045922000_64.4.2401129.95","doi-asserted-by":"crossref","first-page":"e12196","DOI":"10.1002\/pul2.12196","article-title":"The social and economic disadvantage in pulmonary hypertension: a work (still) in progress","volume":"13","author":"Bernardo","year":"2023","journal-title":"Pulm Circ"},{"key":"2024112623045922000_64.4.2401129.96","doi-asserted-by":"crossref","first-page":"e12120","DOI":"10.1002\/pul2.12120","article-title":"Prediction of patient outcomes through social determinants of health: the Pulmonary Hypertension Association Registry (PHAR) evaluation","volume":"12","author":"Grinnan","year":"2022","journal-title":"Pulm Circ"},{"key":"2024112623045922000_64.4.2401129.97","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1513\/AnnalsATS.202003-234RL","article-title":"Urban-rural disparities in pulmonary hypertension mortality","volume":"17","author":"Mac\u00edas","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2024112623045922000_64.4.2401129.98","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201207-1290OC"},{"key":"2024112623045922000_64.4.2401129.99","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1164\/rccm.201709-1821ST","article-title":"Health disparities in patients with pulmonary arterial hypertension: a blueprint for action. An official American Thoracic Society statement","volume":"196","author":"Talwar","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024112623045922000_64.4.2401129.100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/diseases8020022","article-title":"Psychosocial and financial burden of therapy in USA patients with pulmonary arterial hypertension","volume":"8","author":"Helgeson","year":"2020","journal-title":"Diseases"},{"key":"2024112623045922000_64.4.2401129.101","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-2600(18)30268-6","article-title":"Pulmonary hypertension: the unaddressed global health burden","volume":"6","author":"Rich","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024112623045922000_64.4.2401129.102","first-page":"e202014","article-title":"Pulmonary hypertension in the developing world: local registries, challenges, and ways to move forward","volume":"2020","author":"Idrees","year":"2020","journal-title":"Glob Cardiol Sci Pract"},{"key":"2024112623045922000_64.4.2401129.103","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ccm.2023.03.010","article-title":"Health care disparities in pulmonary arterial hypertension","volume":"44","author":"Bernardo","year":"2023","journal-title":"Clin Chest Med"},{"key":"2024112623045922000_64.4.2401129.104","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1513\/AnnalsATS.202109-1051OC","article-title":"Hispanic ethnicity and social determinants of health in pulmonary arterial hypertension: the Pulmonary Hypertension Association Registry","volume":"19","author":"Bernardo","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2024112623045922000_64.4.2401129.105","doi-asserted-by":"crossref","first-page":"20458940211013671","DOI":"10.1177\/20458940211013671","article-title":"Pulmonary arterial hypertension in pregnancy \u2013 a systematic review of outcomes in the modern era","volume":"11","author":"Low","year":"2021","journal-title":"Pulm Circ"},{"key":"2024112623045922000_64.4.2401129.106","first-page":"260","article-title":"Pregnancy considerations in the multidisciplinary care of patients with pulmonary arterial hypertension","volume":"9","author":"Coursen","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"2024112623045922000_64.4.2401129.107","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1164\/rccm.202302-0230VP","article-title":"Access to medically necessary reproductive care for individuals with pulmonary hypertension","volume":"208","author":"Sonntag","year":"2023","journal-title":"Am J Respir Crit Care Med"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01129-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:22:21Z","timestamp":1740381741000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01129-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":107,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,10,31]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1183\/13993003.01129-2024"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01129-2024","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}